Contact us Demo our platform
Case Study

Metabolon Elucidates Molecular Signatures That Explain the Benefits of Reducing Sodium Intake

Metabolon’s Global Discovery Panel and Short Chain Fatty Acids Targeted Panel reveal the probable mechanism of action (MoA) that explains the benefits of reducing sodium consumption in hypertensive patients.

Metabolon helped the research group analyze the metabolic profiles of hypertensive patients. The goal was to elucidate metabolic signatures associated with reduced sodium intake in hypertensive patients and thereby provide mechanistic insights that explain the cardiovascular health benefits of a reduced sodium diet.

Talk With An Expert About Your Project

Metabolon helped the research group analyze the metabolic profiles of hypertensive patients. The goal was to elucidate metabolic signatures associated with reduced sodium intake in hypertensive patients and thereby provide mechanistic insights that explain the cardiovascular health benefits of a reduced sodium diet.

Talk With An Expert About Your Project
Metabolon Elucidates Molecular Signatures That Explain the Benefits of Reducing Sodium Intake

The Challenge: Exploring the Molecular Outcomes of Dietary Sodium Reduction in Hypertensive Patients

Hypertension, also known as high blood pressure (BP), is a medical condition where the force of blood circulating in the arteries is consistently too high. This condition makes it harder for the heart to pump blood. If left untreated, hypertension can lead to serious health complications, including cardiovascular disease (CVD), kidney disease, and vision loss.
High sodium intake is recognized as one of the main risk factors for hypertension. Previous studies have shown that dietary sodium reduction lowers BP, CVD, and mortality.1 Despite this well-established relationship, the underlying mechanism of action (MoA) is not well understood. The present study analyzed serum samples from a randomized, double-blind, placebo-controlled cross-over clinical trial (Unique identifier: NCT00152074) of dietary sodium reduction in hypertensive patients. Comparisons were made based on race and sex.

Metabolon Insight: Metabolon Helps Profile the Metabolic Profiles of Hypertensive Patients

This group utilized the Metabolon Global Discovery Panel to profile the serum samples of Black patients with hypertension (n = 64) on a reduced sodium diet.2 The research group also used Metabolon’s Short Chain Fatty Acids Targeted Panel to profile serum samples from 145 patients with hypertension (42% Black, 19% Asian, and 34% female) on a low sodium diet.3 Metabolon offered this group the most comprehensive solution to analyze the metabolic profiles of hypertensive patients. The goal was to elucidate metabolic signatures associated with reduced sodium intake in hypertensive patients, providing mechanistic insights that explain the cardiovascular health benefits of a reduced sodium diet.

The Solution: Metabolomics Reveals Molecular Signatures of a Low Sodium Intake Diet

Untargeted metabolomics demonstrated that dietary sodium reduction significantly increased the plasma levels of β-hydroxyisovalerate and methionine sulfone. These changes were associated with changes in cardiovascular phenotypes. For example, increased β-hydroxyisovalerate was associated with reduced systolic BP (SBP) and pulse pressure (PP).  Methionine sulfone was associated with reduced diastolic BP (DBP) and improved skin capillary density (microcirculation).
Targeted metabolomics showed that reduced sodium intake significantly increased the levels of many short-chain fatty acids (SCFAs). The levels of 2-methylbutyric acid (2-methylbutyrate) increased in both males and females, while increases in butyric acid (butyrate), caproic acid (hexanoate), isobutyric acid (isobutyrate), isovaleric acid (isovalerate), and valeric acid (valerate) were significant in females only. Changes in SCFAs were associated with changes in cardiovascular phenotypes. Increased circulating isovaleric acid was associated with reduced BP. Increased isobutyric acid was associated with reduced PP and BP. Finally, increased valeric acid was associated with decreased carotid-femoral pulse wave velocity (cfPWV).

The Outcome: Metabolomics Unravels the Mechanisms That Explain the Benefits of Reducing Sodium Intake

Untargeted and targeted metabolomics reveal a probable MoA that explains the benefits of reducing sodium consumption in hypertensive patients. This study shows that dietary sodium reduction alters the metabolome and that there is a sex difference in SCFA response to sodium reduction. These findings suggest that changes in circulating SCFAs may underlie the BP responses to dietary sodium reduction in females but not males. Metabolomic profiling can detect small molecule metabolic products in response to environmental changes, which could serve as biomarkers or underlying mechanisms for biological response to dietary intervention.

References

1. Wang YJ, Yeh TL, Shih MC, Tu YK, Chien KL. Dietary Sodium Intake and Risk of Cardiovascular Disease: A Systematic Review and Dose-Response Meta-Analysis. Nutrients. Sep 25 2020;12(10)doi:10.3390/nu12102934

2. Chen L, He FJ, Dong Y, Huang Y, Harshfield GA, Zhu H. Sodium Reduction, Metabolomic Profiling, and Cardiovascular Disease Risk in Untreated Black Hypertensives. Hypertension. Jul 2019;74(1):194-200. doi:10.1161/HYPERTENSIONAHA.119.12880

Chen L, He FJ, Dong Y, et al. Modest Sodium Reduction Increases Circulating Short-Chain Fatty Acids in Untreated Hypertensives: A Randomized, Double-Blind, Placebo-Controlled Trial. Hypertension. Jul 2020;76(1):73-79. doi:10.1161/HYPERTENSIONAHA.120.14800

Related Case Studies

See All Case Studies
✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.